SereNeuro is developing SN101, a first-in-class iPSC-derived cell therapy designed to relieve osteoarthritis knee pain without opioids. Preclinical, Baltimore.
Investors 1
| Date | Name | Website |
| 05.12.2024 | Johns Hopk... | ventures.j... |
Mentions in press and media 1
| Date | Title | Description |
| 24.05.2026 | Maryland Stem Cell Research Commission: $12.6 Million Awarded To Advance Regenerative Medicine Research | The Maryland Stem Cell Research Commission announced 38 new awards totaling more than $12.6 million through the Maryland Stem Cell Research Fund (MSCRF) to support stem cell and regenerative medicine research, technology development, commer... |